An Improved Preparation of Aromatase Inhibitor 4-Hydroxyandrost-4-ene-3,17-dione
摘要:
The title compound has been prepared in 47% overall yield from androst-4-ene-3,17-dione (1) by a two-step sequence comprising hydrox-ylation of 1 with OsO4 / H2O2, followed by dehydration of the resultant diols 3 in alkaline medium.
In an effort to generate new steroidal aromatase inhibitors, formestane (4-hydroxyandrost-4-ene-3,17-dione) (1) was biotransformed by Rhizopus oryzae to yield the known 4 beta,5 alpha-dihydroxyandrostane-3,17-dione as the major product (5) and bioconverted by Beauveria bassiana to afford the known reduced 4,17 beta-dihydroxyandrost-4-en-3-one (6) and 3 alpha,17 beta-dihydroxy-5 beta-androstan-4-one (7) and the new 4,11 alpha,17 beta-trihydroxyandrost-4-en-3-one (8). All the metabolites showed more potent activities than their parent congener in the aromatase and MCF-7 breast cancer assays. The bioactivities and structural elucidation of these metabolites as well as the semisynthesis of formestane (1) from testosterone (2) are reported herein.
466. Experiments on the synthesis of substances related to the sterols. Part LIV. Degradative and synthetical studies on the A-ring of androst-4-ene-3 : 17-dione